Latest Coronavirus news
FDA Approves Pfizer Boosters for Teens Aged 16 to 17
posted December 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Drug to Help Immunocompromised Fend Off COVID-19
posted December 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
Risk Factors ID’d for Postdischarge Thrombosis in COVID-19 Patients
posted December 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
Long-Term Glycemic Control Cuts Risk for Severe COVID-19 With T2DM
posted December 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD 
Type 2 Diabetes Linked to Worse Menopausal Symptoms .jpg)
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk 
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
Parts of the World Seeing New COVID-19 Variant 
HHS, NIH Unveil Vaccine Initiative to Protect Against Future Pandemics 
Hospital-Onset SARS-CoV-2 Infection During Omicron Linked to Morbidity Monthly Specialist Briefings
Stay Connected
